Monitoring of the Cost of Medicines Used for Peritoneal Dialysis in Patients With Chronic Kidney Disease

Socìalʹna farmacìâ v ohoronì zdorov'â
doi 10.24959/sphhcj.15.22
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National University of Pharmacy

Related search

Pharmacoepidemiological and Pharmacoeconomic Research of the Medicines’ Usage of Peritoneal Dialysis in the Treatment of the Patients With Chronic Kidney Disease

Socìalʹna farmacìâ v ohoronì zdorov'â
2015English

Modification of Laparoscopic Catheter Setting for Peritoneal Dialysis in Patients With Chronic Kidney Disease

Reports of Vinnytsia National Medical University
2019English

Metabolic Implications of Peritoneal Dialysis in Patients With Acute Kidney Injury

Peritoneal Dialysis International
MedicineNephrology
2013English

Puk19 - Cost-Utility of Sucroferric Oxyhydroxide for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients Undergoing Dialysis in Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Peritoneal Dialysis in End-Stage Renal Disease Patients With Preexisting Chronic Liver Disease and Ascites

American Journal of Medicine
Medicine
1992English

The Cost of Care for People With Chronic Kidney Disease

Canadian Journal of Kidney Health and Disease
Nephrology
2019English

Cost Analysis of Hemodialysis and Peritoneal Dialysis Access in Incident Dialysis Patients

Peritoneal Dialysis International
MedicineNephrology
2013English

Optimal Start in Dialysis Shows Increased Survival in Patients With Chronic Kidney Disease

PLoS ONE
Multidisciplinary
2019English

A Study of Lipid Profile in Chronic Kidney Disease in Pre- Dialysis Patients

International Journal of Medical Research and Review
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy